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Malaria parasites vary in phenotypic traits of biomedical or biological interest such as growth rate, viru-
lence, sex ratio and drug resistance, and there is considerable interest in identifying the genes that
underlie this variation. An important ﬁrst step is to determine trait heritability (H
2). We evaluate two
approaches to measuring H
2 in natural parasite populations using relatedness inferred from genetic
marker data. We collected single-clone Plasmodium falciparum infections from 185 patients from the
Thailand–Burma border, monitored parasite clearance following treatment with artemisinin combination
therapy (ACT), measured resistance to six antimalarial drugs and genotyped parasites using 335 micro-
satellites. We found strong relatedness structure. There were 27 groups of two to eight clonally identical
(CI) parasites, and 74 per cent of parasites showed signiﬁcant relatedness to one or more other parasites.
Initially, we used matrices of allele sharing and variance components (VC) methods to estimate H
2.
Inhibitory concentrations (IC50) for six drugs showed signiﬁcant H
2 (0.24 to 0.79, p ¼ 0.06 to 2.85  
10
29), demonstrating that this study design has adequate power. However, a phenotype of current
interest—parasite clearance following ACT—showed no detectable heritability (H
2 ¼ 0–0.09, ns) in
this population. The existence of CI parasites allows the use of a simple ANOVA approach for quantifying
H
2, analogous to that used in human twin studies. This gave similar results to the VC method and
requires considerably less genotyping information. We conclude (i) that H
2 can be effectively measured
in malaria parasite populations using minimal genotype data, allowing rational design of genome-wide
association studies; and (ii) while drug response (IC50) shows signiﬁcant H
2, parasite clearance following
ACT was not heritable in the population studied.
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1. INTRODUCTION
Measurement of heritability (H
2)—the degree to which a
phenotypic trait is determined by genotype—is central to
quantitative genetic analysis (Falconer & Mackay 1996).
For example, traits with high H
2 are expected to respond
rapidly to selection, and mapping of genes that underlie
traits with high H
2 requires smaller sample sizes than
for traits with weak heritability. Accurate measures of
trait H
2 can be made in organisms that are readily crossed
in the laboratory and reared in common environmental
conditions (Falconer & Mackay 1996). Alternatively,
heritability can be measured using pedigrees (Kruuk
et al. 2000; Havill et al. 2010). However, for many
organisms, genetic crosses are difﬁcult to perform
and reliable pedigree information is not available.
Furthermore, for many biomedical traits of interest,
measurement in a controlled laboratory situation is
impossible. For example, biologists working on malaria
are interested to know why some parasite genotypes
cause disease in humans, while others do not (Doumbo
et al. 2009). In this case, disease severity is only possible
to observe in humans and cannot be evaluated experimen-
tally in the progeny of genetic cross. For this and other
phenotypes, heritability should ideally be measured in
natural populations.
One possible approach to measuring H
2 in natural
populations involves inferring relatedness using genetic
markers, as individuals sharing alleles at multiple loci
are more likely to be closely related than individuals shar-
ing alleles at few loci (Thompson 1974; Ritland 2000;
Blouin 2003; Csillery et al. 2006). There are two general
approaches to doing this. First, identity-by-state (IBS)
allelic information at each locus can be used to infer
groups of related individuals (i.e. sibs, half-sibs, etc.),
and then patterns of phenotypic variation within and
between these groups can be used to determine H
2
(Thomas et al. 2000; Fernandez & Toro 2006). Second,
allele-sharing measures can be used to estimate related-
ness between pairs of individuals, without categorizing
pairs into particular relationship classes (Ritland 1996,
2000; Klaper et al. 2001). However, all available methods
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natural populations, which is limited for many organisms
(Csillery et al. 2006; Shikano 2008).
Malaria parasites are haploid protozoans with mixed
mating systems. Inbreeding predominates in low trans-
mission regions (Paul et al. 1995; Anderson et al. 2000)
and related or clonally identical (CI) parasites are fre-
quently sampled within populations. Malaria parasites
show extensive variation in many traits of biomedical or
biological interest, including drug resistance (Fidock
et al. 2008), growth rate (Reilly et al. 2007), virulence
(Mackinnon et al. 2002) and sex ratio (Read et al. 1992;
West et al. 2001). Loci underlying some malaria traits
have been mapped effectively using linkage analysis, but
genetic crosses required for such studies are cumbersome,
expensive and unsuitable for many clinically related traits
(Su et al. 2007). Furthermore, detailed SNP maps, and
the potential for whole-genome sequencing of popu-
lations of parasites, have led to excitement about
mapping the genes underlying these traits by genome-
wide association (Su et al. 2007). For efﬁcient design of
such studies, it would be ideal ﬁrst to know whether the
traits of interest have a genetic basis and to use the
extent of H
2 to estimate appropriate sample sizes.
We evaluate the use of inferred relatedness for estimat-
ing H
2 in natural malaria parasite sampled from a single
clinic on the Thailand–Burma border. We use two differ-
ent approaches. First, we inferred relatedness and
phenotypic similarity between all pairs of parasites and
generated estimates of H
2 using variance components
(VC) methods (Blangero et al. 2001). Second, we used
only identical multilocus genotypes recovered from differ-
ent patients, and estimated H
2 using ANOVA, with
methods analogous to those used in studies of human
twins or clonal plants (Lynch & Walsh 1998). The VC
approach models the contribution of additive variation
only and ignores dominance effects or epistasis, so we
are technically measuring narrow-sense heritability (h
2)
with this method. In contrast, the ANOVA method esti-
mates the broad-sense heritability (H
2), because genetic
variation among CI parasites can be both additive and
epistatic. We have used the notation for broad-sense
heritability (H
2) throughout the manuscript for both
methods, both for clarity and because dominance is not
relevant to haploid organisms such as blood-stage
malaria.
We examined two different types of traits. Drug resist-
ance is known to have a strong genetic basis (Hayton & Su
2004) and so provides an important positive control for
our methods. We also investigated a trait of current
topical interest: parasite clearance rate (CR) following
treatment with artemisinin-based combination therapies
(ACTs; Dondorp et al. 2009). ACTs are the ﬁrst-line
treatment for malaria in the majority of malaria endemic
countries and result in extremely rapid clearance of para-
sites from the blood. Typically, 95 per cent of patients are
parasite-negative by day 2 of treatment (White 2008).
However, considerably slower clearance has been
observed in some southeast Asian locations, leading to
concern about the development of resistance (White
2008; Dondorp et al. 2009). It is currently unclear to
what extent variation in CR is determined by parasite
genetics or to patient or environmental factors. Estimates
of H
2 for this trait are of particular interest as
genome-wide association studies (GWASs) have been
proposed to try to identify the parasite genes that underlie
variation in CR. Evidence of strong heritability for this
trait comes from a recent study of Cambodian parasites
(Anderson et al. 2010).
2. MATERIAL AND METHODS
(a) Collection of parasites
We collected 5 ml of Plasmodium falciparum-infected blood
samples with greater than 0.5 per cent parasitaemia from
patients visiting the malaria clinic at Mawker-Thai on the
Thailand–Burma border, prior to treatment with ACTs.
This clinic serves people on both sides of the border; 90
per cent of patients travel from within a 10 km radius
around the clinic (F. Nosten 2004, personal communi-
cation). We excluded patients who (i) had taken malaria
treatment within 60 days, (ii) were pregnant, or (iii) were
co-infected with P . vivax.
(b) Measurement of parasite clearance
Thin smears were collected prior to parasite treatment and at
24 and 48 h post-treatment for all patients. We measured the
parasite reduction ratio (PRR), deﬁned as (1 þ parasite den-
sity24 or 48h)/(1 þ parasite densityadmission). For the subset of
patients monitored every 6 h, we measured the ﬁrst-order
CR. This was quantiﬁed by plotting the natural log of para-
site density against time since treatment in hours and
measuring the slope.
(c) Measurement of in vitro resistance
Infected blood samples were transported to the laboratory in
Mae Sot within 4 h of collection, where we measured in vitro
response to six drugs using a 48 h [
3H] hypoxanthine incor-
poration assay (Desjardins et al. 1979; Brockman et al. 2000).
This test measures growth by assaying incorporation of [
3H]
hypoxanthine in parasites cultured in 96-well plates. The
drugs tested were chloroquine (CQ), quinine (QN), meﬂo-
quine (MFQ), lumefantrine (LUM), artesunate (AS) and
dihydro-artemisinin (DHA). Tests were performed in duplicate
at each of 11 doubling drug concentrations using a starting
parasitaemia of 0.5 to 1 per cent (Anderson et al. 2005).
(d) Microsatellite genotyping
We initially genotyped seven microsatellite loci to identify
and exclude infections containing multiple clones (Anderson
et al. 2005). We determined relationships between infections
containing a predominant single clone by genotyping micro-
satellite markers spaced at approximately 50 kb intervals
across the genome. We genotyped 15 parasites twice to
measure genotyping reproducibility: only markers that
showed 100 per cent reproducibility in comparisons of the
15 duplicated samples were included in the dataset. Marker
positions, oligos and genotyping methods are listed in
electronic supplementary material, table S1.
(e) Measurement of relatedness
Relatedness is generally estimated for diploid species (Blouin
et al. 1996). This study differs in that we are interested in
relatedness between blood-stage parasites, which are the
haploid products of meiosis. This is akin to measuring relat-
edness between gametes. We measured the proportion of
shared alleles (ps) between all pairwise combinations of para-
sites and plotted 12ps as a UPGMA tree using PHYLIP
(Felsenstein 1993). Parasites that differed at less than 5 per
cent of loci were assumed to be identical-by-descent (IBD)
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pared frequency distributions of observed pairwise allele
sharing with expectations from randomly generating
unrelated parasites using the observed allele frequencies. In
addition, we simulated expected allele sharing for haploid
parasites derived from the same zygote, and for parasites
derived from zygotes with one common parent. These simu-
lations were performed using the observed allele frequencies
at each locus using POPTOOLs v. 3.2.0. (http://www.cse.csiro.
au/poptools/index.htm).
(f) Heritability (H
2) estimation
We measured H
2 using two different methods.
(i) VC H
2 estimate
The VC approach uses relatedness between all pairs of para-
sites in the dataset to estimate H
2 and is equivalent to the
methods used for the analysis of multi-generational family
studies of humans (Blangero et al. 2001). We used the pro-
portion of shared alleles (Blouin 2003) as a simple metric
of relatedness. Pairs of parasites that are genetically identical
will share alleles at all loci, while pairs of parasites that are
unrelated will share just a few alleles that are IBS by
chance. Conventional VC methods for pedigree-based
linkage analysis were used, except that matrices of inferred
relatedness were used instead of the kinship matrix derived
from pedigree data. For H
2 estimation, the parasite pheno-
typic covariance matrix was modelled as V ¼ Rs2
a þ Is2
e,
where R is the relationship matrix (equal to twice the kinship
matrix), I is an identity matrix, s2
a is the variance contributed
by additive genetic factors and s2
e is the remaining (environ-
mental and unmodelled genetic) variance. H
2 is then
estimated as H2 ¼ s2
a=ðs2
a þ s2
eÞ. We used this procedure to
estimate H
2 of both log-transformed measures of in vitro
drug resistance, PRR24 and PRR48.
(ii) ANOV A-based estimate
For this analysis, we used only CI parasite genotypes recov-
ered from two or more individuals. We compared the
variance of CR and IC50 phenotypes within and among
clonal lineages of parasites, and estimated H
2 from the
mean-squares terms in the ANOVA as described in Lynch &
Walsh (1998). In brief, we determined the within- and
among-clone mean squares (MSe and MSb) for each trait.
The total genetic variance ðs2
GÞ is estimated as
ðMSb   MSeÞ=n. n is the weighted mean number of patients
infected with each CI genotype and is calculated as follows:
n ¼½ T  ð
P
n2
i =TÞ =ðN   1Þ, where T is the total number
of patients, N is the number of different clones and ni is
the number of patients infected with the ith clone. The
environmental variance ðs2
EÞ is estimated from the within-
clone variation as MSe, and so H2 ¼ s2
G=ðs2
G þ s2
EÞ.
(g) Evaluating the effects of treatment type,
patient age and patient gender
Patient age, patient gender and treatment type may poten-
tially inﬂuence phenotype and were therefore included in
the analysis. Each patient was treated with one of ﬁve differ-
ent ACT treatment regimens. These ﬁve ACTs were divided
into three groups for analysis: (i) group 1: meﬂoquine
hydrochloride (8 mg kg
21) þ artesunate (4 mg kg
21) for 3
days (MAS3) or 7 days (MAS7); (ii) group 2: dihydroartemi-
sinin 7 mg kg
21/piperaquine 56 mg kg
21 body weight into
four doses at 0, 8, 24 and 48 h (DP4) or into three daily
doses (DP3); and (iii) group 3: ﬁxed dose combination
tablets (20 mg of artemether/120 mg of lumefantrine; Coar-
tem, Novartis, Basel, Switzerland) as six doses over 3 days,
administered by patient weight (COA6a). We evaluated the
inﬂuence of these three independent variables on PRR24,
PRR48, CR and IC50. To correct for the effects of these
covariates, we used residuals from the regression analysis
to examine H
2.
3. RESULTS
(a) Relationships between parasite isolates
The analysis is based on 185 infections containing a single
parasite clone, for which measures of clearance, IC50 for
six drugs and microsatellite genotype data (335 markers)
are available. The microsatellite loci were highly poly-
morphic with 1–23 (mean ¼ 11.04, median ¼ 11,
s.d. ¼ 3.95) alleles per locus and expected heterozygosity
of 0–0.92 (mean ¼ 0.74, median ¼ 0.79, s.d.¼0.16). No
more than seven (3.7%) genotypes were missing at any
locus. The relationships between the parasites are sum-
marized in ﬁgure 1. We found 27 clusters comprising
two to eight parasites that differ by less than 5 per cent
and are effectively IBD across the genome. These are
referred to as CI genotypes. The few differences observed
are distributed across the genome rather than in blocks.
They are therefore most likely to be due to genotyping
error and/or mutation. For the 61 (33%) patients for
whom detailed 6-hourly clearance data were available,
there were seven clusters of CI parasites, with two to
four parasites per cluster (ﬁgure 1a).
Figure 1b shows the distribution of allele sharing
between all pairwise comparisons for the 185 parasites
(30340 comparisons). The main peak is situated
around 0.20–0.35. There is a tail to the right of this,
suggesting parasites of intermediate relatedness. Finally,
the peak at 0.95–1.0 shows parasite pairs that are CI.
For comparison, we plotted the simulated distributions
of allele sharing for different relatedness classes
(ﬁgure 1c). The main peak in the observed data corre-
sponds precisely with allele sharing expected for
unrelated genotypes. We used the upper value of the
simulated distribution for unrelated parasites (0.3556)
to evaluate the proportion of parasites that show signiﬁ-
cant relatedness. Seventy-four per cent of parasite
isolates showed ps . 0.3556 to one or more other
parasites in the dataset, suggesting strong relatedness
structure. Thirty-six per cent of these parasites were CI
(ps ¼ 0.95–1.00) to one or more other parasites in the
dataset. Our simulations suggest that parasites that show
signiﬁcant relatedness but are not CI are either derived
from the same zygote (0.5317 , ps , 0.7425) or share
one common parent (0.3474 , ps , 0.5616).
(b) Heritability of in vitro resistance
IC50 data for the six drugs is summarized in table 1. H
2
estimates for IC50 values are shown in table 2 and
ﬁgure 2. We found signiﬁcant H
2 for ﬁve of the six
drugs using VC methods. Three drugs (MFQ, QN and
LUM) showed high H
2 (0.60–0.79, p ¼ 4.8   10
25
to 7.6   10
29), while the three other drugs (CQ,
DHA and AS) showed more marginal H
2 (0.17–0.39,
p ¼ 0.02–0.08). Analysis of residuals to remove the
effect of covariates (treatment regimen, patient age and
sex) generated marginally lower H
2 for all six drugs.
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Figure 1. Relatedness structure of the parasite population. (a) UPGMA tree showing the relationships between 185 parasite
isolates. The tree is constructed from a pairwise matrix of the statistic (1–ps), where ps is the proportion of alleles shared
between the two isolates. These measures were calculated using 335 microsatellite markers genotyped. The bars mark 27
groups of parasites that differ by less than 5 per cent and are assumed to be IBD. The dots indicate the members of seven
groups of parasites that differ by less than 5 per cent among the 61 parasites with detailed clearance data. (b) Pairwise measure-
ments of allele sharing (ps). The y-axis is truncated to effectively display the range of relatedness within the population.
(c) Simulated distribution of expected allele sharing for parasites in different relatedness classes. We simulated allele sharing
expected in parasites derived from the same inbred oocyst (AA), from the same outcrossed oocyst (both from AB), from
two related (half-sib) oocysts (from AB and BC) and from two unrelated oocysts (AB and CD). The observed ps distribution
demonstrates that parasites are predominantly unrelated with some CI parasites and contributions from other relatedness
classes.
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(using log-transformed data or residuals) also gave similar
results, with all drugs except CQ showing signiﬁcant H
2.
The estimates of H
2 were marginally lower for four of the
six drugs using ANOVA compared with variance com-
ponents, with an average difference of 0.07 (0.01–0.16).
(c) Heritability of CR
We calculated H
2 of PRRs (PRR24 and PRR48). These
calculations were performed on the natural logs of the
phenotype data, as well as on the residuals following
removal of the effects of gender, age and treatment
type. H
2 estimates derived from both simple ANOVA
and more complex VC methods are shown in table 2
and ﬁgure 3. We found non-signiﬁcant H
2 for both
PRR24 and PRR48 (H
2 ¼ 0 2 0.09, ns) using both esti-
mation methods and using analysis with and without
covariate effects.
There were 61 patients for whom 6-hourly measures
of parasite density were made allowing estimation of
ﬁrst-order CR. Slopes for parasite density against time
post-treatment ranged from 0.12 to 0.43 (mean
(+1 s.d.) ¼ 0.24+0.07) and ﬁtted well with a linear
model (r
2 ¼ 0.90+0.06; ﬁgure 3). There were seven CI
parasite genotypes recovered from two to four different
patients each. We found dramatic differences in clearance
proﬁle between many CI parasites (ﬁgure 3), consistent
with the non-signiﬁcant H
2 for clearance-related par-
ameters. Furthermore, statistical analysis using both
VC- and ANOVA-based methods did not reveal
signiﬁcant effects of parasite genotype on CR (ANOVA:
H
2¼0.16, n.s.; VC: H
2¼0.02+0.25, p ¼ 0.47), and
remained insigniﬁcant after correction for age, sex and
treatment type (ANOVA: H
2¼0.17, n.s.; VC:
H
2¼0.03+0.25, p ¼ 0.46).
4. DISCUSSION
These data demonstrate that (i) Thai parasite populations
show strong relatedness structure, (ii) H
2 can be effec-
tively measured in natural parasite populations using
inferred relatedness, (iii) in vitro drug resistance is
strongly heritable and (iv) parasite CR following ACTs
is not strongly inﬂuenced by parasite genotype on the
Thailand–Burma border. We divide the discussion into
three sections. First, we discuss the efﬁcacy of two
methods for measuring H
2. Second, we evaluate the
implications of these results for genetic mapping of
ART resistance. Finally, we discuss the utility of H
2
estimation in malaria.
(a) Heritability estimation
We used 335 microsatellite markers distributed across the
genome to estimate relationships between 185 parasites
and used two methods to estimate H
2. The genetic data
reveal strong relatedness structure in the data. However,
given the number and allelic diversity of the micro-
satellites genotyped, we were surprised that pairwise
relatedness plots (ﬁgure 1b,c) did not clearly demarcate
common relatedness categories. There are two likely
reasons for this. First, gamete fusion between related
parasites (i.e. inbreeding) may result in IBS information
poorly deﬁning relatedness categories. Second, the two
parasite genomes that fuse to form a zygote may be
unequally represented in the meiotic products. This has
been well documented in Plasmodium genetic crosses
in the laboratory, where selection results in
over-representation of one of the two parental genotypes
(Walker-Jonah et al. 1992). Hence, this parasite system
is rather different from systems in which diploid
individuals inherit one-half of their genome from each
parent.
We were extremely successful in measuring heritability
using inferred relatedness. Encouragingly, both the VC
method, using matrices of inferred relatedness between
all parasites, and ANOVA methods that use only CI para-
sites gave very similar estimates of H
2. The reason for this
comes from inspection of patterns of relatedness. Thirty-
six per cent of parasites sampled were CI with one or
more other parasites. Because CI parasites are easily
identiﬁed and the relationships between them are unam-
biguous, the ANOVA method effectively captures the
relatedness class that is maximally informative for H
2.A
practical advantage of the ANOVA approach is that CI
parasites can be identiﬁed with very few loci—in this
data as few as six loci are sufﬁcient (ﬁgure 4)—so large
numbers of parasites can be rapidly screened. In contrast,
the VC approach makes fuller use of the data because
more distantly related parasites are included in H
2 esti-
mation. However, as distantly related parasites are on
average less informative for H
2, and relatedness estimates
for such parasites show high variance (Csillery et al. 2006)
and may be prone to bias owing to population structure
(Shikano 2008), this does not greatly improve precision
of H
2 estimates. As noted in the introduction, the
ANOVA method estimates the broad-sense heritability
(H
2) owing to additive and/or epistatic genetics, while
the VC approach explicitly models narrow-sense
heritability (h
2). The close correspondence between
measures derived from both VC and ANOVA approaches
strongly suggests that additive variation is a principal
determinant of phenotypic variation at the traits studied
and that epistasis makes little contribution.
We used a simple allele-sharing measure to infer relat-
edness between parasites. This metric has the virtue of
simplicity, but does not take into account background
allele sharing that occurs by chance between unrelated
parasites. We also computed kinship coefﬁcients between
pairs of parasites following Ritland (1996) using the pro-
gram SPAGEDI (Hardy & Vekemans 2002), which
accounts for background allele sharing. Reassuringly, we
found that simple allele sharing (ps) and Ritland’s more
complex metric give extremely similar estimates of H
2
(data not shown). The lack of bias may be due in part
to the size of the dataset used.
Table 1. Summary of inhibitory concentration (IC50) for six
antimalarial drugs.
AS
(nM)
CQ
(nM)
DHA
(nM)
LUM
(nM)
MFQ
(nM)
QN
(nM)
min 0.40 48.0 0.30 4.0 6.10 79.20
max 11.60 918.5 28.50 157.9 353.10 1862.10
mean 2.25 256.29 3.55 48.56 82.21 746.68
median 1.9 210.8 2.7 40.3 70.1 650.8
n 152 175 165 155 176 152
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(Hayton & Su 2004) and provides a positive control
for our methods. Genetics explains a large proportion
(49–79%) of the variance in IC50 values for LUM, QN
and MFQ, but between 17 and 39 per cent of the variance
for AS, DHA and CQ. By implication, factors other than
genetics explain much variation in these drugs. The low
H
2 estimate of CQ response seems especially surprising
given that the major gene determining resistance, the
chloroquine resistance transporter (pfcrt), is well charac-
terized (Fidock et al. 2000). However, the pfcrt-76T
SNP conferring resistance is ﬁxed on the Thailand–
Burma border, so all parasites show high IC50. The low
H
2 estimate suggests that much of the remaining variation
in IC50 measures observed does not have a genetic basis.
We list possible non-genetic explanations for the variation
in IC50 observed:
—The assays of IC50 were conducted in blood samples
collected from patients. Differences in red blood cell
physiology between patients, such as permeability to
drugs, may inﬂuence assay results.
—Experimental error in preparation of drug plates may
add noise to the data and contribute to the unexplained
variation. Laboratory-based studies of drug resistance
generally repeat drug assays multiple times to maximize
accuracy (Ferdig et al. 2004). Unfortunately this is
not possible in the ﬁeld situation when isolates are
processed fresh from the patient without culture
adaptation.
Table 2. Heritability estimates using variance components and ANOV A-based methods. p-values are shown in italics
(p , 0.001) and in bold (p , 0.05).
clones n
ln transformed
p
residuals
a
p H
2 s.e. H
2 s.e.
variance components
AS 24 151 0.39 0.16 0.0174 0.34 0.18 0.0406
CQ 25 174 0.17 0.13 0.08 0.04 0.12 0.3718
DHA 25 164 0.30 0.15 0.0278 0.25 0.16 0.0666
LUM 20 154 0.60 0.11 4.84   10
25 0.57 0.12 0.0002
MFQ 26 175 0.79 0.06 2.85   10
29 0.77 0.06 1.47   10
28
QN 20 151 0.65 0.10 7.56   10
25 0.62 0.11 8.50   10
25
PRR24 27 184 0
b — 0.00 0.00 0.5
PRR48 27 184 0
b — 0.03 0.10 0.3704
ANOVA
AS 24 61
c 0.33 0.15 0.0123 0.27 0.15 0.0339
CQ 25 66
c 0.22 0.14 0.0551 0.08 0.14 0.2730
DHA 25 64
c 0.31 0.14 0.0143 0.25 0.15 0.0434
LUM 20 54
c 0.56 0.13 ,0.0001 0.52 0.14 0.0003
MFQ 26 69
c 0.69 0.09 ,0.0001 0.67 0.09 ,0.0001
QN 20 55
c 0.49 0.14 0.0004 0.52 0.13 0.0002
PRR24 27 74
c 0.02 0.13 0.4148 0.09 0.13 0.2377
PRR48 27 74
c 20.02 0.13 0.5408 0.05 0.13 0.3514
aResiduals were generated from multiple regression of phenotype against treatment regimen, patient age and gender.
bBoundary of parameter space encountered: s.e. and p-value not output by SOLAR.
cn is lower for the ANOVA as only CI parasites are used.
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Figure 2. Heritability of in vitro drug resistance and parasite clearance. White bars show H
2 estimated by ANOVA, while
shaded bars show H
2 estimates using variance components. Results are reported (a) using log-transformed IC50 data or
clearance data (PRR24 and PRR48) and (b) for residuals following regression against patient age, gender and treatment category
(see text). H
2 estimates derived by both methods are very similar.
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measures resulting in non-genetic differences between
parasites (Slatkin 2009). Currently, little is known
about epigenetic effects in P . falciparum for traits
other than var gene expression (Volz et al. 2010): the
role of epigenetics is unknown for the phenotypes
examined here.
(b) CR is not signiﬁcantly heritable on the
Thai–Burma border
We examined clearance following ARTas an example of a
trait that cannot be measured in the laboratory, but is of
considerable biomedical interest. Slow clearance of para-
sites following treatment with ACTs has been widely
interpreted as a sign of impending resistance to artemisi-
nin derivatives (White 2008; Carrara et al. 2009;
Dondorp et al. 2009). While we observed extensive vari-
ation in clearance parameters (PRR24,P R R 48 and CR),
these data provided no evidence that these measures are
inﬂuenced by parasite genetic factors on the Thailand–
Burma border. There are two possible explanations for
this result. First, our measures of clearance may not be
sufﬁciently accurate to detect signiﬁcant H
2, because we
recorded parasite density at 24 h intervals for most
patients. More frequent measures may be needed to accu-
rately document CR. We note that detailed (6-hourly) CR
information was available for a subset of 61 patients.
However, this subsample also failed to detect signiﬁcant
H
2 for clearance.
Second, clearance may truly have little genetic basis
and is determined by factors other than parasite genetics
in this population. What might these other factors be? We
evaluated three possible factors—patient age (a surrogate
measure of immunity), patient gender and treatment
regimen. However, of these three, only gender marginally
inﬂuenced PRR24. Mathematical modelling work
suggests that the age structure of parasite populations
within the patient at the time of treatment may signiﬁ-
cantly inﬂuence clearance proﬁles (L. White 2007,
personal communication), as different life stages vary
in their response to artemisinin derivatives. Similarly,
heterogeneity in patient immune status as a consequence
of exposure to infection could inﬂuence clearance
patterns (Luxemburger et al. 1997), while human genetic
factors could also play a role (Weatherall 2008). The key
point here is that many factors other than parasite
genotype may inﬂuence CR.
It is important to note that these results apply
speciﬁcally to parasite populations sampled from the
14
12
10
8
6
4
2
0
l
n
 
p
a
r
a
s
i
t
e
 
d
e
n
s
i
t
y
l
n
 
p
a
r
a
s
i
t
e
 
d
e
n
s
i
t
y
l
n
 
p
a
r
a
s
i
t
e
 
d
e
n
s
i
t
y
14
12
10
8
6
4
2
0
14
12
10
8
6
4
2
0
0 6 12 18 24 30 36 42 48 54 60 66 72 0 6 12 18 24 30 36 42 48 54 60 66 72 0 6 12 18 24 30 36 42 48 54 60 66 72
0 6 12 18 24 30 36
time post-treatment (h)
time post-treatment (h) time post-treatment (h) time post-treatment (h)
42 48 54 60 66 72
Figure 3. Clearance curves for groups of genetically similar parasite clones. The graphs show plots of parasite density sampled
at 6-hourly intervals post-treatment. Parasite density is plotted on a natural log scale, which linearizes the decay curves. In many
cases, CI parasites show dramatic differences in clearance proﬁles.
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rara et al. (2009) show that there has been a decrease in
CR in this region, but that this did not start until
2003–2004. As the parasites examined here were
sampled prior to 2003, it is possible that genes inﬂuen-
cing clearance have spread to the Thailand–Burma
border since this time. We have recently examined H
2
for CR in a population in western Cambodia, where
extremely slow clearance and high failure rates have
been reported (Dondorp et al. 2009). Interestingly, we
observed high H
2 in western Cambodia (0.56–0.58),
clearly implicating parasite genetic factors (Anderson
et al. 2010). We suggest larger studies are required on
the Thailand–Burma border, entailing 6-hourly measures
of clearance, to determine whether parasite clearance has
a genetic basis in present-day parasite populations.
(c) Applications of H
2 for malaria research
Our ability to rapidly genotype or sequence malaria gen-
omes now make GWASs an attractive alternative to
linkage mapping for locating genes that underlie traits of
biomedical or biological importance (Su et al. 2007). As
such studies are expensive, it is important to ﬁrst demon-
strate that the traits of interest have a signiﬁcant genetic
basis. H
2 estimates provide one way to achieve this. We
provide one example of a trait of enormous public
health signiﬁcance that does not have a genetic basis
in the population studied: clearance following ART.
GWASs of this trait would therefore be unlikely to
succeed in this population. Virulence and sex ratio are
two other traits where the role of parasite genetics is
uncertain, yet both are envisaged as adaptive traits with
a genetic basis (West et al. 2001; Mackinnon & Read
2004). Studies of H
2 would provide a test for such
models and would provide preliminary data to justify
GWASs on such traits. To extend this argument further,
the magnitude of H
2 is also useful for estimating sample
sizes for GWASs, as traits with strong H
2 require smaller
sample sizes than traits with weak H
2. Typically, sample
size scales with the square of H
2,s on for a trait with
H
2 ¼ 1 is four times less than n for a trait with H
2 ¼ 0.5
(Williams & Blangero 1999). However, we note that trait
architecture is also critically important in determining
mappability. True polygenic traits determined by many
genes of small effect size may be difﬁcult to map even if
they show high H
2 (Goring et al.2 0 0 7 ).
H
2 measures are also useful for assessing the robust-
ness of phenotype measures that are known to have a
strong genetic basis. In laboratory studies, precision of
phenotypes can be directly assessed by repeated measure-
ment. For many malaria traits, such repeated
measurement is not feasible. However, as related parasites
are sampled within populations, estimating H
2 provides
an alternative approach to assessing robustness of pheno-
type measures. The IC50 data presented here, which were
measured directly using parasite-infected blood from
patients, provides an example of this application. Our
results indicate that IC50 data collected in this way
showed poor repeatability for three or six drugs examined.
Our ability to measure H
2 is strongly dependent on the
existence of related or identical parasites within popu-
lation samples. In P . falciparum, the proportion of CI
parasites within populations is dependent on levels
of transmission and inbreeding (Anderson et al. 2000).
In low-transmission regions, multiple clone infections
are rare, simplifying genotype–phenotype association.
Hence, measurement of H
2 is easiest in low-transmission
regions such as southeast Asia and South America. How-
ever, even in high-transmission African countries, a large
proportion of meioses are expected to result from
inbreeding (Babiker et al. 1994; Razakandrainibe et al.
2005). CI genotypes may also be sampled in such regions
(Conway & McBride 1991), and could be used to
estimate H
2.
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